Concepedia

Namita Joshi

NJ

13

Publications

318

Citations

11

H-Index

2014

Active since

Affiliations

Pharmerit (United States)(Current)

Taiho Oncology (United States)

University of California San Diego

Yale Cancer Center

Instituto de Investigación Biomédica de Salamanca

Namita Joshi is an author at Pharmerit (United States) specializing in health sciences, hematology, and medicine.

ORCID

Top concepts

Publications per year

2014–2024

13

Publications

13

Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

Mahmoud Elsawy, Julio C. Chávez, Irit Avivi et al. · Blood · 2022 · 69 citations · Full text

, , +19

Relationship Between Depression and Physical Activity, Disability, Burden, and Health-Related Quality of Life Among Patients with Arthritis

Namita Joshi, Rahul Khanna, Ruchit Shah · Population Health Management · 2014 · 48 citations

, , +23

Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States

Viktor Chirikov, Ingrid Ma, Namita Joshi et al. · Value in Health · 2018 · 31 citations · Full text

Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment

Sandy Srinivas, Ateesha F. Mohamed, Sreevalsa Appukkuttan et al. · Cancer Medicine · 2020 · 31 citations · Full text

Under-use of Hypomethylating Agents in Patients With Higher-risk Myelodysplastic Syndrome in the United States: A Large Population-based Analysis

Shelby Corman, Namita Joshi, Tim Wert et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 24 citations · Full text

Rows per page

1–5 of 13